MYCELX Technologies (MYX) Share Price, News & Analysis

Company Overview

MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the oil and gas, power, marine, and heavy manufacturing sectors in the Middle East, the United States, Nigeria, Australia and internationally. The company offers oil removal solutions for upstream produced water to oil companies; and hydrocarbons removal services from downstream process wastewater that are used in petrochemical facilities and refineries. It also sells or leases its equipment; and sells consumable filtration media. The company was incorporated in 1994 and is headquartered in Norcross, Georgia.

Key Stats

• Today's Range: 37.50 to 37.50
• 50-Day Range: 35.30 to 49
• 52-Week Range: 35.30 to 66
• Volume: 90,000 shs
• Average Volume: 25,539 shs
• Market Capitalization: £9.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: GBX 95
• Consensus Rating: Buy

MYCELX Technologies Stock Analysis - MarketRank™

MYCELX Technologies scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

MYCELX Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

MYCELX Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of MYCELX Technologies is -340.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of MYCELX Technologies is -340.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

MYCELX Technologies has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for MYX.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

MYCELX Technologies does not currently pay a dividend.

Dividend Growth

MYCELX Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for MYX.

News and Social Media

• Score: 0.8 / 5
• News Sentiment: N/A

News Sentiment

MYCELX Technologies has a news sentiment score of -0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.26 average news sentiment score of Industrials companies.

News Coverage This Week

MarketBeat has tracked 1 news article for MYCELX Technologies this week, compared to 0 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, MYCELX Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought £24,906.36 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

19.26% of the stock of MYCELX Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

41.80% of the stock of MYCELX Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MYX Stock Analysis - Frequently Asked Questions

How have MYX shares performed this year?

MYCELX Technologies' stock was trading at GBX 62 on January 1st, 2024. Since then, MYX stock has decreased by 39.5% and is now trading at GBX 37.50.
View the best growth stocks for 2024 here.

How do I buy shares of MYCELX Technologies?

Shares of MYX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of MYCELX Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MYCELX Technologies investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Abcam (ABC), Advanced Medical Solutions Group (AMS) and Alliance Pharma (APH).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Industrials
• Industry: Pollution & Treatment Controls
• Sub-Industry: N/A
• Current Symbol: LON:MYX
• CUSIP: N/A
• CIK: N/A
• Web: www.mycelx.com
• Phone: +1-770-5343118
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 95
• High Stock Price Target: GBX 95
• Low Stock Price Target: GBX 95
• Potential Upside/Downside: +153.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 12.51
• P/E Growth: N/A
• Net Income: £-3,560,000.00
• Net Margins: -40.30%
• Pretax Margin: N/A
• Return on Equity: -46.97%
• Return on Assets: -24.82%

Debt

• Debt-to-Equity Ratio: 23.15
• Current Ratio: 2.93
• Quick Ratio: 2.97

Sales & Book Value

• Annual Sales: £8.84 million
• Price / Sales: 1.03
• Cash Flow: GBX 19.15 per share
• Price / Cash Flow: 1.96
• Book Value: GBX 25 per share
• Price / Book: 1.50

Miscellaneous

• Outstanding Shares: 24,360,000
• Free Float: N/A
• Market Cap: £9.14 million
• Optionable: Not Optionable
• Beta: 1.00